- Home
- IMMX vs MDIA Comparison
IMMX vs MDIA Comparison
Compare IMMX & MDIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- MDIA
- Stock Information
- Founded
- IMMX 2014
- MDIA 2019
- Country
- IMMX United States
- MDIA United States
- Employees
- IMMX N/A
- MDIA N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- MDIA Broadcasting
- Sector
- IMMX Health Care
- MDIA Consumer Discretionary
- Exchange
- IMMX Nasdaq
- MDIA Nasdaq
- Market Cap
- IMMX 61.1M
- MDIA 51.8M
- IPO Year
- IMMX 2021
- MDIA N/A
- Fundamental
- Price
- IMMX $2.13
- MDIA $1.09
- Analyst Decision
- IMMX Strong Buy
- MDIA
- Analyst Count
- IMMX 1
- MDIA 0
- Target Price
- IMMX $7.00
- MDIA N/A
- AVG Volume (30 Days)
- IMMX 261.4K
- MDIA 92.3K
- Earning Date
- IMMX 08-11-2025
- MDIA 05-20-2025
- Dividend Yield
- IMMX N/A
- MDIA N/A
- EPS Growth
- IMMX N/A
- MDIA N/A
- EPS
- IMMX N/A
- MDIA N/A
- Revenue
- IMMX N/A
- MDIA $116,895,000.00
- Revenue This Year
- IMMX N/A
- MDIA N/A
- Revenue Next Year
- IMMX N/A
- MDIA N/A
- P/E Ratio
- IMMX N/A
- MDIA N/A
- Revenue Growth
- IMMX N/A
- MDIA 268.03
- 52 Week Low
- IMMX $1.26
- MDIA $0.79
- 52 Week High
- IMMX $3.00
- MDIA $5.73
- Technical
- Relative Strength Index (RSI)
- IMMX 45.97
- MDIA 48.06
- Support Level
- IMMX $2.16
- MDIA $1.01
- Resistance Level
- IMMX $2.31
- MDIA $1.14
- Average True Range (ATR)
- IMMX 0.17
- MDIA 0.14
- MACD
- IMMX -0.04
- MDIA -0.02
- Stochastic Oscillator
- IMMX 11.14
- MDIA 13.56
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.